Koninklijke Philips N.V.
(NYSE:PHG) stock declined in Tuesday’s session after the company beat second-quarter earnings estimates but reported weaker order intake, continued challenges in China and underlying margin pressure obscured by a U.S. tariff refund.
The healthcare technology company reported adjusted earnings of 57 cents per share, beating the consensus of 40 cents.
Sales reached $5.068 billion (4.36 billion euros), slightly above the consensus of $5.040 billion.
Comparable sales increased by 4%, driven by growth across all segments.
